BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The International Society for Vaccines - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The International Society for Vaccines
X-ORIGINAL-URL:https://isv-online.org
X-WR-CALDESC:Events for The International Society for Vaccines
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250424
DTEND;VALUE=DATE:20250425
DTSTAMP:20260405T181245
CREATED:20250124T171555Z
LAST-MODIFIED:20250417T091637Z
UID:3722-1745452800-1745539199@isv-online.org
SUMMARY:RSV Vaccines
DESCRIPTION: SPEAKERS: \n \n  \nGlobal Lifelong Burden of RSV – Louis Bont\, M.D.\, Ph.D\, Professor\, University Medical Center Utrecht \n  \n \n  \nPrefusion-F Stability and Vaccine Efficacy: Structure-Based Vaccines for RSV/HMPV/PIV – Peter Kwong\, Ph.D\, Richard J. Stock Professor\, Biochemistry and Molecular Biophysics Columbia University \n  \n \n  \nPIV5-vectored RSV Intranasal Vaccine (BLB201) is Safe and Immunogenic in Healthy Adults and Young Children\, Hong Jin\, Ph.D\, Chief Scientific Officer\, CynVac/Blue Lake Bio \n  \n \n  \nRSVPreF Vaccine in Older Adults and At-Risk Adults Aged 18 – 59 Years – Kumar Ilangovan\, MD\, MSPH\, MMCi\, FACP\, FAAP\, Director\, Vaccines Clinical Research & Global Clinical Lead\, RSV Adult Vaccine Program\, Pfizer Vaccine \n  \n\nTime: \nUS & Europe: 06:00 (PDT) | 09:00 (EDT) 14:00 (BST) | 15:00 (CEST)\nSouth America: 10:00 (Argentina) | 07:00 (Mexico)\nAfrica: 14:00 (West Africa) | 15:00 (South Africa) | 16:00 (East Africa)\nAsia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST)\nAustralia: 21:00 (AWST) | 23:00 (AEST) | 23:00 (AEDT) \n\n\nJoin the webinar here
URL:https://isv-online.org/event/rsv-vaccines-mini-symposium/
CATEGORIES:Mini-Symposia
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/01/2025-April-24_Mini-Symposium.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250430T110000
DTEND;TZID=UTC:20250430T170000
DTSTAMP:20260405T181245
CREATED:20250226T090134Z
LAST-MODIFIED:20250407T131545Z
UID:4576-1746010800-1746032400@isv-online.org
SUMMARY:Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
DESCRIPTION:Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults \nP.J. (Paul) Wichgers Schreur\, Wageningen Bioveterinary Research\, Netherlands \n  \n\nTime: \nUS & Europe: 08:00 (PDT) | 11:00 (EDT) | 16:00 (BST) |17:00 (CEST)\nSouth America: 12:00 noon (Argentina) | 10:00 (Mexico)\nAfrica: 04:00 (West Africa) | 05:00 (South Africa) | 06:00 (East Africa)\nAsia: 08:30 (IST) | 11:00 (CST) | 12:00 (KST)\nAustralia: 23:00 (AWST) | 01:00 (AEST) 1 May | 20:00 1 May (AEDT) \n\n\nJoin the webinar here\n 
URL:https://isv-online.org/event/safety-and-immunogenicity-of-the-live-attenuated-candidate-vaccine-hrvfv-4s-against-rift-valley-fever-in-healthy-adults/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/png:https://isv-online.org/wp-content/uploads/2025/02/30-April-ISV-Webinar-Announcement.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250508
DTEND;VALUE=DATE:20250509
DTSTAMP:20260405T181245
CREATED:20250429T115332Z
LAST-MODIFIED:20250508T131254Z
UID:4988-1746662400-1746748799@isv-online.org
SUMMARY:Next Generation Vaccinologists May 2025 Webinar
DESCRIPTION:SPEAKERS: \nDelivering Pandemic Vaccines in 100 Days — What Will It Take?\, Dr Renske Hesselink\, CEPI \n  \n  \n  \n \nAdvancing saRNA Delivery: Evaluating Novel PEI-Inspired Polymers as Non-Viral Carriers\, Lisa Opsomer\, PhD student\, Ghent University \n  \n  \n  \n\nTime:  \nThursday\, May 8th  \nUS & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (BST) | 17:00 (CEST)\nSouth America: 12:00 (Argentina) | 10:00 (Mexico)\nAfrica: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)\nAsia: 20:30 (IST) | 23:00 (CST) | 24:00 (KST)\nAustralia: 23:00 (AWST) | 01:00 (AEST) – 9 May | 22:00 (AEDT) – 9 May \n\n\nJoin the webinar here
URL:https://isv-online.org/event/next-generation-vaccinologists-may-2025-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/05/Announcement-NextGen-May-2025-webinar-AT-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250521
DTEND;VALUE=DATE:20250523
DTSTAMP:20260405T181245
CREATED:20250520T083017Z
LAST-MODIFIED:20250520T083557Z
UID:5299-1747785600-1747958399@isv-online.org
SUMMARY:Vaccines and Therapies for Chronic Viral Diseases
DESCRIPTION:
URL:https://isv-online.org/event/vaccines-and-therapies-for-chronic-viral-diseases/
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://isv-online.org/wp-content/uploads/2025/05/Vaccines_PPT-slide.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250528T110000
DTEND;TZID=America/New_York:20250528T120000
DTSTAMP:20260405T181245
CREATED:20250123T124728Z
LAST-MODIFIED:20250513T140023Z
UID:3494-1748430000-1748433600@isv-online.org
SUMMARY:Computational Modelling of Vaccine Responses
DESCRIPTION:SPEAKER \n \nComputational Modelling of Vaccine Responses  \nTal Einav\, LaJolla Institute of Immunology\, United States \n  \n  \n  \n\nTime: \nUS & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (BST) | 17:00 (CEST)\nSouth America: 12:00 (Argentina) | 09:00 (Mexico)\nAfrica: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)\nAsia: 20:30 (IST) | 23:00 (CST) | 24:00 (KST)\nAustralia: 23:00 (AWST) | 01:00 (AEST) – 29 May | 22:00 (AEDT) – 29 May \n\nJoin the webinar here\n 
URL:https://isv-online.org/event/computational-modelling-of-vaccine-responses/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/png:https://isv-online.org/wp-content/uploads/2025/01/ISV-28-May-Webinar-FINAL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250612
DTEND;VALUE=DATE:20250613
DTSTAMP:20260405T181245
CREATED:20250610T072611Z
LAST-MODIFIED:20250610T081740Z
UID:5461-1749686400-1749772799@isv-online.org
SUMMARY:NextGen June Webinar
DESCRIPTION:Title: CTH522/CAF®01-induced Th17 T cells contribute to protection against infection with Chlamydia trachomatis \nSpeaker: Dr. Nina Nguyen\, Statens Serum Institut \n\n\nTitle: Vaccine adjuvants\, delivery systems and immunostimulators \nSpeaker: Dr. Dennis Christensen\, Statens Serum Institut \n\nTime: \nUS & Europe: 07:00 (PDT) | 10:00 (EDT) 15:00 (BST) | 16:00 (CEST)\nSouth America:  08:00 (Mexico) | 11:00 (Argentina)\nAfrica: 15:00 (West Africa) | 16:00 (South Africa) | 17:00 (East Africa)\nAsia: 19:30 (IST) | 22:00 (CST) | 23:00 (KST)\nAustralia: 22:00 (AWST) | 00:00 (+1\, AEST) \n\n\nJoin the webinar here
URL:https://isv-online.org/event/nextgen-june-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/06/Announcement-NextGen-June-2025-webinar-updated-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250626
DTEND;VALUE=DATE:20250627
DTSTAMP:20260405T181245
CREATED:20250124T171809Z
LAST-MODIFIED:20250626T113811Z
UID:3725-1750896000-1750982399@isv-online.org
SUMMARY:HIV Vaccines
DESCRIPTION:Speakers\, Presentation Title\, and Bio’s:\n\n\n\nTITLE: Why HIV Vaccines Are Still Needed\nSPEAKER: Glenda Gray\, South African Medical Research Council\n  \nGlenda Gray\, MBBCH\, FCPaeds (SA)\, DSc (honoris causa\, Simon Fraser University 2013)\, DSc (honoris causa\, Stellenbosch University 2018)\, Honorary Doctorate in Law (Rhodes University\, 2019)\, an NRF A rated scientist\, was the first female president and CEO of the South African Medical Research Council (SAMRC) and is currently the Chief Scientific Officer at the SAMRC. \nGray trained as a medical doctor and pediatrician at the University of the Witwatersrand and co-founded and led the internationally renowned Perinatal HIV Research Unit based at the Chris Hani Baragwanath Hospital in Soweto. As a clinical researcher\, she is internationally known for her research in HIV vaccines and interventions to prevent mother to child transmission of HIV. She is the Co-PI of the of the NIH funded HIV Vaccine Trials Network and is responsible for the expansion of HIV vaccine research in Africa. In 2002\, she was awarded the Nelson Mandela Health and Human Rights Award for pioneering work done in the field of Mother-to-Child Transmission of HIV-1. \nShe is a member of the Academy of Science in South Africa\, the African Academy of Science and The World Academy of Sciences (TWAS). She is one of a handful of foreign associates of the USA National Academy of Medicine\, of the National Academies of Science\, and has served on their Global Health Board. She was the Chair for the Global Alliance for Chronic Diseases (GACD). Gray has also been awarded the IAPAC “Hero of Medicine” award for work done in the field of HIV treatment in children and adults. \n\n\n\nTITLE: Clinical Progress Toward Vaccine Induction of HIV Broadly Neutralizing Antibodies\nSPEAKER: William Schief\, Moderna\n  \nWilliam Schief is Vice President\, Protein Design\, Moderna; Professor\, Immunology and Microbiology\, Scripps Research; and Executive Director\, Vaccine Design\, IAVI Neutralizing Antibody Center at Scripps. He has a BS in Applied Mathematics from Yale University and a PhD in Physics from the University of Washington. His work focuses on computation-guided and structure-based design of vaccines and therapeutics for a wide range of diseases. For HIV vaccine development\, the topic of this ISV 2025 mini-symposium\, Dr. Schief is pursuing the strategy of germline-targeting vaccine design with many collaborators. This strategy aims to induce broadly neutralizing antibodies (bnAbs) through a series of vaccinations that first activates naïve bnAb-precursor B cells sharing key genetic features of bnAbs and then guides B cell somatic hypermutation and affinity maturation to produce bnAbs in germinal center and memory B cells\, plasma cells\, and serum. \n\n\n\nTITLE: Immune Correlates of Protection for HIV Vaccines\nSPEAKER: Peter Gilbert\, Fred Hutch Cancer Center\n  \nDr. Peter Gilbert\, Professor of Biostatistics at the Fred Hutchinson Cancer Center and the University of Washington\, conducts statistical science research for randomized trials of candidate vaccines for HIV\, SARS-CoV-2\, and other infectious pathogens. He specializes in statistical methods for analyzing these trials in pursuit of understanding “immune correlates of protection\,” which involve immune response biomarkers as well as genotypic and immunophenotypic pathogen features. A central application of this research is development of biomarker surrogate endpoints that can be used to infer the level of vaccine efficacy against infectious disease outcomes. Dr. Gilbert is a Principal Investigator of the Statistical Data Management Center for the NIH NIAID-sponsored HIV Vaccine Trials Network. \n\n\n\nTITLE: The Progress of Polyvalent DNA Prime and Protein Boost HIV Vaccine (PDPHV)\nSPEAKER: Shan Lu\,UMASS Chan Medical School and Worcester HIV Vaccine (WHV)\n  \nShan Lu is a Professor Emeritus in the Department of Medicine\, University of Massachusetts Medical School\, USA.  He was a pioneer in nucleic acid vaccines in the early 1990s and has continuously worked to advance this field in the past three decades. He advocated the heterologous prime-boost vaccination concept and developed the world’s first polyvalent DNA prime protein boost HIV vaccine into human clinical studies\, which showed robust and broadly cross-reactive immune responses. \nBesides being a US board-certified physician in internal medicine with more than 20 years’ clinical practice\, Dr. Lu has managed major NIH-funded vaccine development programs\, including GMP manufacturing\, FDA IND filing and human clinical studies. He has broad biotech industry collaborations\, and joined Worcester HIV Vaccine in 2022\, serving as its Chief Scientific Officer.  He was the past president of International Society for Vaccines (ISV) and is the current co-chair of Corporate Partnership Program (CPP) at the International AIDS Society (IAS). \n\nModerators Bio’s:\n\n\n\n\n\nMODERATOR: Lindsey Baden\, Brigham and Women’s Hospital \nLindsey Baden\, MD\, serves as vice president of Clinical Research for Brigham and Women’s Hospital. In his role as vice president\, Baden provides comprehensive oversight of clinical research at the Brigham and is responsible for developing and implementing operational strategies\, as well as building and maintaining the necessary infrastructure and resources in support of our clinical research mission and operational goals. He also oversees the Center for Clinical Investigation\, serves as the primary liaison with Harvard Catalyst/Harvard Medical School\, and has responsibility for increasing and maintaining research relationships across the Brigham\, Mass General Brigham and our local collaborators. \nBaden\, an infectious diseases specialist\, joined the Brigham in 1995 and has served in several critical leadership roles\, including directing the Infectious Diseases Immunocompromised Host program at the Brigham and Dana-Farber\, acting as program leader for the Clinical Research Centers of Harvard Catalyst and directing the Center for Clinical Investigation. A professor at Harvard Medical School and deputy editor of The New England Journal of Medicine\, Baden is a highly respected clinician and clinical investigator. He has received continuous funding from the National Institutes of Health (NIH) throughout his career and is an expert in developing new therapeutics and vaccines. In response to the COVID-19 crisis\, he was integral in the design and conduct of the pivotal NIH co-sponsored vaccine efficacy trials\, Of note\, he is the co-principal investigator for the phase 3 COVE study\, which evaluated the mRNA-1273 (Moderna) vaccine candidate against COVID-19. This phase three trial\, conducted in part at the Brigham\, has led to the unprecedented rapid emergency use authorization\, subsequent licensure and broad global use of this highly effective vaccine. \n\n\n\n\n\nMODERATOR: Nyaradzo Mgodi\, University of Zimbabwe Clinical Trials Research Center\n\nNyaradzo Mavis Mgodi is a clinical pathologist with over 10 years of experience conducting HIV clinical trials in women of reproductive age in Africa. She is lead investigator in multiple clinical trials assessing various biomedical HIV prevention interventions\, like vaginal rings\, oral PrEP\, injectable PrEP and broadly neutralizing antibodies. Nyaradzo serves as a member of the HPTN Executive Committee and a scientific reviewer for the Medical Research Council of Zimbabwe and has served as a technical advisor for the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) survey. She is a member of the Policy and Implementation Steering Committee for the Global Evaluation of Microbicide Sensitivity (GEMS) project. She served as a Programme Organizing Committee member for HIVR4P 2018 and Conference Advisory Committee member for the International AIDS Society in 2017. \n\nTime Zones:\n\nAmerica & Europe: 06:00 (PDT) |09:00 (EDT) | 14:00 (BST) | 15:00 (CEST) \nCentral & South America: 07:00 (Mexico) |10:00 (Argentina) \nAfrica: 14:00 (West Africa) | 15:00 (South Africa) |  16:00 (East Africa) \nAsia & Australia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST) |  21:00 (AWST) | 23:00 (AEST)\n\n\n\n\n\n\n\n\nJoin the webinar here
URL:https://isv-online.org/event/hiv-vaccines/
CATEGORIES:Mini-Symposia
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/01/ISV-Mini-Symposium-HIV-Vaccines.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250701
DTEND;VALUE=DATE:20250702
DTSTAMP:20260405T181245
CREATED:20250123T125206Z
LAST-MODIFIED:20250630T163732Z
UID:3499-1751328000-1751414399@isv-online.org
SUMMARY:Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use
DESCRIPTION:Title: Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use. \nSpeaker: Mateusz Hasso-Agopsowicz\, World Health Organization\, Switzerland \n  \n\n\nTime Zones:\n\n\nAmerica & Europe: 06:00 (PDT) |09:00 (EDT) | 14:00 (BST) | 15:00 (CEST) \nCentral & South America: 07:00 (Mexico) |10:00 (Argentina) \nAfrica: 14:00 (West Africa) | 15:00 (South Africa) |  16:00 (East Africa) \nAsia & Australia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST) |  21:00 (AWST) | 23:00 (AEST)\n\n\n\n\n\n\n\n\n\nJoin the webinar here
URL:https://isv-online.org/event/estimating-the-impact-of-vaccines-in-reducing-antimicrobial-resistance-and-antibiotic-use/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/01/July-1_Mateusz-Hasso-Agopsowicz-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250710
DTEND;VALUE=DATE:20250711
DTSTAMP:20260405T181245
CREATED:20250701T070225Z
LAST-MODIFIED:20250701T184912Z
UID:5645-1752105600-1752191999@isv-online.org
SUMMARY:Next Generation Vaccinologists July Webinar
DESCRIPTION:Title: Bench to the City\nSpeaker: Dr. Ravi Degun\, Ernst Young – Parthenon\n\n  \n  \n\n\n\nTitle: From Pipettes to Pitches: Navigating a Career in Nanomedicine\nSpeaker: Dr. Martin Rabel\, Cytiva\n\n\n  \n  \n\n\nTime:\nUS & Europe: 07:00 (PDT) | 10:00 (EDT) 15:00 (BST) | 16:00 (CEST)\nSouth America: 11:00 (Argentina) | 08:00 (Mexico)\nAfrica: 15:00 (West Africa) | 16:00 (South Africa) | 17:00 (East Africa)\nAsia: 19:30 (IST) | 22:00 (CST) | 23:00 (KST)\nAustralia: 22:00 (AWST) | 00:00 (+1\, AEDT) \n\n\nJoin the webinar here
URL:https://isv-online.org/event/next-generation-vaccinologists-july-webinar-series/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/07/NextGen-10th-July-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250729
DTEND;VALUE=DATE:20250730
DTSTAMP:20260405T181245
CREATED:20250123T125408Z
LAST-MODIFIED:20250721T163223Z
UID:3501-1753747200-1753833599@isv-online.org
SUMMARY:Development and Clinical Study in Multiple Phase 1 and 2 trials of infectious disease and cancer vaccines based on the MVA platform
DESCRIPTION:Title: Development and Clinical Study in Multiple Phase 1 and 2 trials of infectious disease and cancer vaccines based on the MVA platform \nSpeaker: Don Diamond\, City of Hope\, United States \n  \n  \n\nTime Zones:\n\n\n\nAmerica & Europe: 08:00 (PDT) |11:00 (EDT) | 16:00 (BST) | 17:00 (CEST) \nCentral & South America: 09:00 (Mexico) |12:00 noon (Argentina) \nAfrica: 16:00 (West Africa) | 17:00 (South Africa) |  18:00 (East Africa) \nAsia & Australia: 20:30 (IST) | 23:00 (CST) | 00:00 midnight (KST) |  23:00 (AWST) | 01:00 (AEST) 30 July\n\n\n\n\n\n\nJoin the webinar: www.zoom.us/j/91080572379 ​​\n 
URL:https://isv-online.org/event/isv-july-webinar-series/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/01/Don-Diamond-Webinar-July-29-v2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250807
DTEND;VALUE=DATE:20250808
DTSTAMP:20260405T181245
CREATED:20250722T114913Z
LAST-MODIFIED:20250722T115311Z
UID:5823-1754524800-1754611199@isv-online.org
SUMMARY:Next Generation Vaccinologists August Webinar
DESCRIPTION:  \n\nTitle: Mapping B Cell Precursors in HIV: A Southern African Perspective on Germline-Targeting Vaccine Strategies\n\nSpeaker: Dr. Judie Magura\, Africa Health Research Institute (AHRI)\, South Africa \n  \n \n\nTitle: Being resourceful in an under-resourced research landscape: leveraging optimism and collaboration; Focus: foot and mouth disease virus (FMDV)\n\nSpeaker: Dr. Keba Lebani\, Botswana International University of Science and Technology\, Botswana \n  \nModerator: Dr. Sandra Depelsenaire\, Vaxxas Pty Ltd \n  \n\n\nTime Zones:\n\nAmerica & Europe: 01:00 (PDT) |04:00 (EDT) | 09:00 (BST) | 10:00 (CEST) \nCentral & South America: 02:00 (Mexico) |05:00 (Argentina) \nAfrica: 09:00 (West Africa) | 10:00 (South Africa) |  11:00 (East Africa) \nAsia & Australia: 13:30 (IST) | 16:00 (CST) | 17:00 (KST) |  16:00 (AWST) | 18:00 (AEST) \n\n\n\n\n\nJoin the webinar here
URL:https://isv-online.org/event/next-generation-vaccinologists-august-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/07/Announcement-NextGen-Aug-2025-webinar.pptx-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250827
DTEND;VALUE=DATE:20250828
DTSTAMP:20260405T181245
CREATED:20250805T183909Z
LAST-MODIFIED:20250818T200204Z
UID:5860-1756252800-1756339199@isv-online.org
SUMMARY:Speeding up vaccine design and antibody discovery using cryoEM and AI/ML
DESCRIPTION:Title:Speeding up vaccine design and antibody discovery using cryoEM and AI/ML\n \nSpeaker: Andrew Ward\, Scripps Research\, United States \n  \n  \nMODERATOR:  Camila Coelho\, Icahn School of Medicine at Mount Sinai \n\n\n\nTime Zones:\n\nAmerica & Europe: 08:00 (PDT) |11:00 (EDT) | 16:00 (BST) | 17:00 (CEST)\n\nCentral & South America: 09:00 (Mexico) |12:00 noon (Argentina) \nAfrica: 16:00 (West Africa) | 17:00 (South Africa) |  18:00 (East Africa) \n\nAsia & Australia: 20:30 (IST) | 23:00 (CST) | 00:00 midnight (KST) |  23:00 (AWST) | 01:00 (AEST) 28 August \n\n\n\n\nJoin the webinar: https://zoom.us/j/99951071640\n 
URL:https://isv-online.org/event/isv-august-webinar/
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/08/2025.08.27_Webinar_Andrew-Ward-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250904
DTEND;VALUE=DATE:20250905
DTSTAMP:20260405T181245
CREATED:20250818T195313Z
LAST-MODIFIED:20250818T195332Z
UID:5879-1756944000-1757030399@isv-online.org
SUMMARY:Next Generation Vaccinologists September Webinar
DESCRIPTION:Title: What could possibly go wrong? Lessons learned the hard way from not thinking about IP early\n\nSpeaker: Dr. Belinda Hartmann\, Uniquest Pty Ltd\n \n  \n \n  \n\nTitle: Developing vaccines using the molecular clamp technology\n\nSpeaker:Dr. Andrew Young\, The University of Queensland\, Australia\n \n  \n  \nModerator: Dr. Sandra Depelsenaire\, Vaxxas Pty Ltd \n  \n\n\nTime Zones:\n\nAmerica & Europe: 01:00 (PDT) |04:00 (EDT) | 09:00 (BST) | 10:00 (CEST) \nCentral & South America: 02:00 (Mexico) |05:00 (Argentina) \nAfrica: 09:00 (West Africa) | 10:00 (South Africa) |  11:00 (East Africa) \nAsia & Australia: 13:30 (IST) | 16:00 (CST) | 17:00 (KST) |  16:00 (AWST) | 18:00 (AEST) \n\n\n\n\n\nJoin the webinar here: zoom.us/j/93291034519 
URL:https://isv-online.org/event/next-generation-vaccinologists-september-webinar/
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/08/Announcement-NextGen-Sep-2025-webinar-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250925
DTEND;VALUE=DATE:20250926
DTSTAMP:20260405T181245
CREATED:20250124T172032Z
LAST-MODIFIED:20250903T074859Z
UID:3728-1758758400-1758844799@isv-online.org
SUMMARY:ISV's Influenza Mini-Symposium
DESCRIPTION:PRESENTERS\n \n09:00 – 09:30 (EDT)\nDevelopment of universal flu vaccines – induction of cross reactive T cells \nGuus Rimmelzwaan \, M.D.\, Ph.D\nProfessor\, TIHO Hannover \n  \n \n09:30 – 10:00 (EDT)\nLeveraging the Power of AAV for Influenza Vaccines \nStacey Schultz-Cherry\, Ph.D\nMember\, Department of Host-Microbe Interactions\nSt Jude Children’s Research Hospital Memphis \n  \n \n10:00 – 10:30 (EDT) \nFluMist Self/Caregiver Administration @ Home \nAllyn Bandell\, Ph.D\nUS Medical Affairs\, Lead – Influenza AstraZeneca \n  \n \n10:30 – 11:00 (EDT) \nCD388: A Novel Long-Acting Antiviral for Pre-Exposure Prophylaxis Against Influenza \nTim Alefantis\, Ph.D\nVice President\, Influenza Strategy\, Cidara \n  \n  \n\nTIME ZONES\nUS & Europe: 06:00 (PDT) / 09:00 (EDT) 14:00 (BST) / 15:00 (CEST) \nSouth America: 10:00 (Argentina) / 07:00 (Mexico) \nAfrica: 14:00 (West Africa) / 15:00 (South Africa) / 16:00 (East Africa) \nAsia: 18:30 (IST) / 21:00 (CST) / 22:00 (KST) \nAustralia: 21:00 (AWST) / 23:00 (AEST) / 23:00 (AEDT) \n\n\nZoom Link: https://zoom.us/j/93155639420
URL:https://isv-online.org/event/influenza-vaccines-mini-symposium/
CATEGORIES:Mini-Symposia
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/01/2025-September-25_Mini-Symposium-Influenza-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251002
DTEND;VALUE=DATE:20251003
DTSTAMP:20260405T181245
CREATED:20250909T193223Z
LAST-MODIFIED:20250909T193545Z
UID:6135-1759363200-1759449599@isv-online.org
SUMMARY:NextGen October webinar
DESCRIPTION:TITLE: COVID-19-related inflammation of the placenta impedes fetal development in pregnant hamsters \nSpeaker: Yana Kumpaneko\, MD\, KU Leuven\, Belgium \n  \n  \n \n  \nTITLE: Building a Positive Research Culture \nSpeaker: Prof. Dr. Adrian Liston\, University of Cambridge\, United Kingdom \n  \n  \n\n\n\nTime Zones:\n\nAmerica & Europe: 07:00 (PDT) |10:00 (EDT) | 15:00 (BST) | 16:00 (CEST)\n\nCentral & South America: 08:00 (Mexico) |11:00 (Argentina) \nAfrica: 15:00 (West Africa) | 16:00 (South Africa) |  17:00 (East Africa) \n\nAsia & Australia: 19:30 (IST) | 22:00 (CST) | 23:00 midnight (KST) |  22:00 (AWST) | 00:00 (+1 AEST) 3 October \n\n\n\n\nJoin the webinar: https://zoom.us/j/91697440883
URL:https://isv-online.org/event/6135/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/09/Announcement-NextGen-Oct-2025-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251028
DTEND;VALUE=DATE:20251031
DTSTAMP:20260405T181245
CREATED:20250123T125956Z
LAST-MODIFIED:20250909T105708Z
UID:3503-1761609600-1761868799@isv-online.org
SUMMARY:2025 ISV Annual Congress
DESCRIPTION:2025 ISV Annual Congress Website here\nRegister here.
URL:https://isv-online.org/event/2025-isv-annual-congress/
LOCATION:Protea Hotel\, Stellenbosch\, South Africa
CATEGORIES:ISV Annual Congress
ATTACH;FMTTYPE=image/png:https://isv-online.org/wp-content/uploads/2025/01/Copy-of-V2-2025-ISV-Congress-postcard-for-MC-A5-Landscape.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251107T095120
DTEND;TZID=UTC:20251107T095120
DTSTAMP:20260405T181245
CREATED:20251107T095120Z
LAST-MODIFIED:20251107T095120Z
UID:6386-1762509080-1762509080@isv-online.org
SUMMARY:Visit ISV's YouTube Channel
DESCRIPTION:
URL:https://isv-online.org/event/visit-isvs-youtube-channel/
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/11/ISV-YouTube-Channel-Presentation.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251113
DTEND;VALUE=DATE:20251114
DTSTAMP:20260405T181245
CREATED:20251103T120650Z
LAST-MODIFIED:20251103T120650Z
UID:6363-1762992000-1763078399@isv-online.org
SUMMARY:NextGen November Webinar
DESCRIPTION:Title: All about microneedle vaccination and the journey of building a vaccine startup \nSpeaker: Dr. Koen van der Maaden\, Leiden University\, the Netherlands\n  \n\n\nTitle: Navigating transitions between academia and industry\, and tips for securing fellowships \nSpeaker: Dr. Kevin M. Koo\, The University of Queensland Centre for Clinical Research (UQCCR)\, Australia \n\n\nModerator: Dr. Sandra Depelsenaire\, Vaxxas Pty Ltd \n\n\nTime: \nUS & Europe: 01:00 (PST) | 04:00 (EDT) 09:00 (GMT) | 10:00 (CET)\nSouth America:  03:00 (CST) | 06:00 (ART)\nAfrica: 10:00 (West Africa) | 11:00 (South Africa) | 12:00 (East Africa)\nAsia: 14:30 (IST) | 17:00 (CST) | 18:00 (KST)\nAustralia: 17:00 (AWST) | 19:00 (AEST) | 20:00 (AEDT) \n\n\nJoin the webinar here
URL:https://isv-online.org/event/nextgen-november-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/10/Slide-November-Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251204
DTEND;VALUE=DATE:20251205
DTSTAMP:20260405T181245
CREATED:20251113T153532Z
LAST-MODIFIED:20251113T153532Z
UID:6805-1764806400-1764892799@isv-online.org
SUMMARY:NextGen December Webinar
DESCRIPTION:  \nTitle: Microcapsules for single-shot vaccination \nSpeaker: Romain Guyon\, PhD\, University of Oxford\, UK\n  \n\n\n\n  \n  \n\n \nTitle: From Dopamine to Vaccine – or: What is it that you do at work\, son? \nSpeaker: Stefan Jungbluth\, PhD\, MBA\, European Vaccine Initiative\, Germany \n\n\n  \nModerator: Allegra Peletta\, PhD\,Vaccine Formulation Institute\, Switzerland\n \n  \n\n\nTime: \nUS & Europe: 07:00 (PST) | 10:00 (EDT) 15:00 (GMT) | 16:00 (CET)\nSouth America:  09:00 (CST) | 12:00 (ART)\nAfrica: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)\nAsia: 20:30 (IST) | 23:00 (CST) | 00:00 (KST)\nAustralia: 23:00 (AWST) | 01:00 (AEST) +1 | 02:00 (AEDT) +1 \n\n\nJoin the webinar here
URL:https://isv-online.org/event/nextgen-december-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/11/Announcement-December-Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251204T100000
DTEND;TZID=UTC:20251204T170000
DTSTAMP:20260405T181245
CREATED:20251217T101826Z
LAST-MODIFIED:20251217T101826Z
UID:7372-1764842400-1764867600@isv-online.org
SUMMARY:NextGen December Webinar
DESCRIPTION:Title: Microcapsules for single-shot vaccination \nSpeaker: Romain Guyon\, PhD\, University of Oxford\, UK\n  \n\n\n\n  \n  \n\n \nTitle: From Dopamine to Vaccine – or: What is it that you do at work\, son? \nSpeaker: Stefan Jungbluth\, PhD\, MBA\, European Vaccine Initiative\, Germany \n\n\n  \nModerator: Allegra Peletta\, PhD\,Vaccine Formulation Institute\, Switzerland\n \n  \n\n\nTime: \nUS & Europe: 07:00 (PST) | 10:00 (EDT) 15:00 (GMT) | 16:00 (CET)\nSouth America:  09:00 (CST) | 12:00 (ART)\nAfrica: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)\nAsia: 20:30 (IST) | 23:00 (CST) | 00:00 (KST)\nAustralia: 23:00 (AWST) | 01:00 (AEST) +1 | 02:00 (AEDT) +1 \n\n\nJoin the webinar here
URL:https://isv-online.org/event/nextgen-december-webinar-2/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/11/Announcement-December-Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T100000
DTEND;TZID=America/New_York:20251217T110000
DTSTAMP:20260405T181245
CREATED:20251113T154126Z
LAST-MODIFIED:20251212T104828Z
UID:6822-1765965600-1765969200@isv-online.org
SUMMARY:Vaccines in the Era of Artificial Intelligence
DESCRIPTION:Title: Vaccines in the Era of Artificial Intelligence. \nSpeaker: Rino Rappuoli\, Biotecnopolo di Siena Foundation\, Italy \n  \n MODERATOR: David Weiner\, Wistar Institute \n\n\n\nTime Zones:\n\n\nAmerica & Europe: 07:00 (PST) |10:00 (EST) | 15:00 (BST) | 16:00 (CEST) \nCentral & South America: 09:00 (Mexico) |12:00 (Argentina) \nAfrica: 16:00 (West Africa) | 17:00 (South Africa) |  18:00 (East Africa) \nAsia & Australia: 20:30 (IST) | 23:00 (CST) | 00:00 (KST) |  23:00 (AWST) | 01:00 (AEST) – 18 December | 02:00 (AEDT) – 18 December \n\n\n\n\n\n\n\n\n\nJoin the webinar here.
URL:https://isv-online.org/event/vaccines-in-the-era-of-artificial-intelligence/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/11/2025.December_Webinar_Rino-Rappuoli-v4-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260108T090000
DTEND;TZID=UTC:20260108T100000
DTSTAMP:20260405T181245
CREATED:20251217T130739Z
LAST-MODIFIED:20260108T085346Z
UID:7370-1767862800-1767866400@isv-online.org
SUMMARY:ISV NextGen January 2026 Webinar
DESCRIPTION:Add to Calendar: here\n\nTitle: European Journey in the field of vaccinology \nSpeaker: Dr. Stéphanie Longet\,Assistant Professor\, Université Saint Etienne\, France \n  \n\n\n\nTitle: Advancing mRNA vaccine engineering to enhance antigen expression \n\nSpeaker: Ameyo Daglus\, Early Career Vaccinologist (Kenya)\, EMJM International Vaccinologist \n\n\n  \nModerator: Alcidia Ramos Barros\, University of Geneva \n  \n\n\nTime: \nUS & Europe: 01:00 (PST) | 04:00 (EDT) 09:00 (GMT) | 10:00 (CET)\nSouth America:  03:00 (CST) | 06:00 (ART)\nAfrica: 10:00 (West Africa) | 11:00 (South Africa) | 12:00 (East Africa)\nAsia: 14:30 (IST) | 17:00 (CST) | 18:00 (KST)\nAustralia: 17:00 (AWST) | 19:00 (AEST) | 20:00 (AEDT) \n\n\nJoin the webinar here
URL:https://isv-online.org/event/isv-nextgen-january-2026-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/12/NextGen-JAN-2026-Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260114T160000
DTEND;TZID=UTC:20260114T170000
DTSTAMP:20260405T181245
CREATED:20251223T124927Z
LAST-MODIFIED:20260115T094536Z
UID:7451-1768406400-1768410000@isv-online.org
SUMMARY:ISV January Webinar
DESCRIPTION:Title: Development of a recombinant influenza vaccine Flublok®\n \nSpeaker: Manon Cox\, ISV President / NextWaveBio  \nModerator: Indresh Srivastava\, Vice President\, Vaccine Development Novavax\n \n  \n\n\n  \nTime: \nUS & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (GMT) | 17:00 (CET)\nSouth America:  10:00 (CST) | 13:00 (ART)\nAfrica: 17:00 (West Africa) | 18:00 (South Africa) | 19:00 (East Africa)\nAsia: 21:30 (IST) | 00:00 (CST) | 01:00 (KST) + 1\nAustralia: 00:00 (AWST) | 10:00 (AEST) + 1 | 03:00 (AEDT) + 1 \n\n\nJoin the webinar here
URL:https://isv-online.org/event/isv-january-2026-webinar/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2026/01/2026-January-Webinar_Manon-Cox.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260122T090000
DTEND;TZID=America/New_York:20260122T100000
DTSTAMP:20260405T181245
CREATED:20251223T144541Z
LAST-MODIFIED:20260115T101732Z
UID:7463-1769072400-1769076000@isv-online.org
SUMMARY:ISV’s Mini-Symposium on Human MetaPneumoVirus
DESCRIPTION:Add to Calendar: here\n\n09:00 – 09:15  Introduction: Nnenna Chime\, MD\, MPH\, PhD\, Sanofi \n\n09:15 – 09:45  (EDT) \nOverview of HMPV vaccine development landscape \nNnenna Chime MD\, MPH\, PhD\, Sanofi \n  \n\n09:45 – 10:15  (EDT) \nComputational design of a potent pre-fusion protein as a human metapneumovirus vaccine​ \nMichael Kishko\, PhD\, Sanofi \n  \n\n10:15 – 10:45  (EDT) \nHMPV and RSV epidemiology: so similar but still different  \nProfessor Albert Osterhaus\, Center of Infection Medicine and Zoonosis Research\, Germany \n  \n\n10:45 – 11:15  (EDT) \nHMPV and Older Adults: Clinical Considerations \nStefan Gravenstein MD\, MPH\, Brown University \n  \n\nTIME ZONES\nUS & Europe: 06:00 (PDT) / 09:00 (EDT) 14:00 (GMT) / 15:00 (CET) \nSouth America: 07:00 (Mexico) / 10:00 (Argentina) \nAfrica: 14:00 (West Africa) / 15:00 (South Africa) / 16:00 (East Africa) \nAsia: 18:30 (IST) / 21:00 (CST) / 22:00 (KST) \nAustralia: 21:00 (AWST) / 23:00 (AEST) / 23:00 (AEDT) \n  \n\nZoom Link: https://zoom.us/j/97827320738
URL:https://isv-online.org/event/isvs-mini-symposium-on-human-metapneumovirus/
CATEGORIES:Mini-Symposia
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2026/01/2026-January-22-_Human-MetaPneumoVirus-Mini-Symposium-v6.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260205T040000
DTEND;TZID=America/New_York:20260205T050000
DTSTAMP:20260405T181245
CREATED:20260112T093354Z
LAST-MODIFIED:20260115T101614Z
UID:7587-1770264000-1770267600@isv-online.org
SUMMARY:ISV NextGen February Webinar
DESCRIPTION:  \nTITLE: Next-Generation Newborn Vaccines for Tuberculosis Prevention \nPRESENTER: Isaac Sakala\, Australian National University \n  \n \n  \nTITLE: Immunopeptidomics-based design of mRNA vaccine formulations against Mycobacterium tuberculosis \nPRESENTER: Laura Van Moortel\, VIB\, Ghent \n  \n  \nModerator: Alcidia Ramos Barros\, University of Geneva \n  \n\nTime Zones:\n\nAmerica & Europe: 01:00 (PST) |04:00 (EST) | 09:00 (GMT) | 10:00 (CET) \nCentral & South America: 03:00 (Mexico) |06:00 (Argentina) \nAfrica: 10:00 (West Africa) | 11:00 (South Africa) |  12:00 (East Africa) \nAsia & Australia: 14:30 (IST) | 17:00 (CST) | 18:00 (KST) |  17:00 (AWST) | 19:00 (AEST) | 20:00 (AEDT) \n\n\n\n\n\nAdd to Calendar: here\nJoin the webinar: here
URL:https://isv-online.org/event/isv-nextgen-february-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2026/01/NoxtGen-FEB-5-2026_Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260211T110000
DTEND;TZID=America/New_York:20260211T120000
DTSTAMP:20260405T181245
CREATED:20260112T093237Z
LAST-MODIFIED:20260206T153933Z
UID:7585-1770807600-1770811200@isv-online.org
SUMMARY:ISV February Webinar
DESCRIPTION:TITLE: HIV Vaccines Beyond Neutralizing Antibodies  \nPRESENTER: Shan Lu\, UMASS Chan Medical School and Worcester HIV Vaccine (WHV) \n\n\nTime: \nUS & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (GMT) | 17:00 (CET)\nSouth America:  10:00 (CST) | 13:00 (ART)\nAfrica: 17:00 (West Africa) | 18:00 (South Africa) | 19:00 (East Africa)\nAsia: 21:30 (IST) | 00:00 (CST) + 1 | 01:00 (KST) + 1\nAustralia: 00:00 (AWST) | 10:00 (AEST) + 1 | 03:00 (AEDT) + 1 \n\n\nJoin the webinar here
URL:https://isv-online.org/event/isv-2026-february-webinar/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2026/02/2026-February-11-Webinar_Shan-Lu.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260305T100000
DTEND;TZID=America/New_York:20260305T110000
DTSTAMP:20260405T181245
CREATED:20260112T093538Z
LAST-MODIFIED:20260302T175259Z
UID:7590-1772704800-1772708400@isv-online.org
SUMMARY:ISV NextGen March Webinar (EST)
DESCRIPTION:TITLE: Impact of needle-free delivery technologies on the vaccine-induced immune responses in pigs \nSpeaker: Inés Có Rives\, University College Cork\, Ireland \n  \nTITLE: Development of an oral immunization strategy against filoviruses \nSpeaker: Juan García-Bernalt\, Research Institute Hospital 12 de Octubre (i+12)\, Spain\n \n  \nModerator: Allegra Peletta\, Vaccine Formulation Institute\, CH \n\n\nTime Zones:\n\nAmerica & Europe: 07:00 (PST) |10:00 (EST) | 15:00 (GMT) | 16:00 (CET)\nCentral & South America: 10:00 (CST) |12:00 (ART)\nAfrica: 16:00 (West Africa) | 17:00 (South Africa) |  18:00 (East Africa)\nAsia & Australia: 19:30 (IST) | 232:00 (CST) | 00:00 +1 (KST) |  23:00 (AWST) | 01:00 +1 (AEST) | 02:00 +1 (AEDT)\n\n\n\n\n\n\n\nJoin the webinar: https://zoom.us/j/94837187771
URL:https://isv-online.org/event/isv-nextgen-march-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2026/02/Slide-MARCH-2026-Webinar-revised.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260311T110000
DTEND;TZID=America/New_York:20260311T120000
DTSTAMP:20260405T181245
CREATED:20260115T103239Z
LAST-MODIFIED:20260115T104525Z
UID:7657-1773226800-1773230400@isv-online.org
SUMMARY:ISV March Webinar
DESCRIPTION:TITLE: Breaking the Cold Chain: The Future of Thermostable Vaccines\nSPEAKER: Indresh Srivastava\, Vice President\, Vaccine Development Novavax\n\n\nModerator: Dr Manon Cox\, NextWaveBio\n\n\n\n\n\n\n\n  \nTime: \n\n\nUS & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (GMT) | 17:00 (CET)\nSouth America:  10:00 (CST) | 13:00 (ART)\nAfrica: 17:00 (West Africa) | 18:00 (South Africa) | 19:00 (East Africa)\nAsia: 21:30 (IST) | 00:00 (CST) | 01:00 (KST) + 1\nAustralia: 00:00 (AWST) | 10:00 (AEST) + 1 | 03:00 (AEDT) + 1 \n\n\nAdd to calendar here.\nJoin the webinar here
URL:https://isv-online.org/event/isv-march-webinar/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2026/01/2026-March-11-Webinar_Indresh-Srivastava.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260408T160000
DTEND;TZID=America/Halifax:20260408T170000
DTSTAMP:20260405T181245
CREATED:20260112T092451Z
LAST-MODIFIED:20260402T001239Z
UID:7582-1775664000-1775667600@isv-online.org
SUMMARY:ISV April Webinar
DESCRIPTION:Speaker: Dr. Baik-Lin Seong\, Yonsei University\, South Korea \n 
URL:https://isv-online.org/event/isv-april-2026-webinar/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2026/04/Baik-Lin-Seong-FINAL.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260424
DTSTAMP:20260405T181245
CREATED:20260129T085205Z
LAST-MODIFIED:20260129T085205Z
UID:7747-1776902400-1776988799@isv-online.org
SUMMARY:ISV’s Mini-Symposium on AI use in Vaccine Development
DESCRIPTION:
URL:https://isv-online.org/event/isvs-mini-symposium-on-ai-use-in-vaccine-development/
ATTACH;FMTTYPE=image/png:https://isv-online.org/wp-content/uploads/2025/01/Mini-Symposia-3.png
END:VEVENT
END:VCALENDAR